A double-blind, multi-center extension study to evaluate the safety and efficacy of Q8003 in patients with acute moderate to severe pain
Phase of Trial: Phase III
Latest Information Update: 23 May 2012
At a glance
- Drugs Morphine/oxycodone (Primary)
- Indications Pain
- Focus Adverse reactions; Registrational
- 09 Jun 2008 Status change from recruiting to completed, according to clinicaltrials.gov.
- 10 Dec 2007 New trial record.